Anesthesia considerations during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Kenneth P Rothfield, Kathy Crowley

Journal: Surgical oncology clinics of North America 2013;21(4):533-41

PMID: 23021714

Full Text on Elsevier Science View on PubMed

Abstract

This article outlines the anesthetic management of patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. This includes a discussion of preoperative evaluation, hemodynamic monitoring, fluid and electrolyte therapy, and temperature management. An understanding of the unique physiologic consequences of this procedure is essential to ensure good outcomes and avoid patient injuries.

Address: Department of Anesthesiology, Saint Agnes Hospital, Baltimore, MD 21229, USA. [email protected]

DOI: 10.1016/j.soc.2012.07.003

Link outs

Free resources

Medical:

https://medlineplus.gov/ovariancancer.html

Subscription / membership required

Full Text Sources:

MeSH Terms: Anesthesia, General, Antineoplastic Combined Chemotherapy Protocols, Carcinoma, Chemotherapy, Cancer, Regional Perfusion, Colloids, Combined Modality Therapy, Crystalloid Solutions, Fluid Therapy, Hemodynamics, Humans, Hyperthermia, Induced, Infusions, Parenteral, Isotonic Solutions, Peritoneal Neoplasms